Application
CSDE1 Antibody (C-term) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the CSDE1 antibody detected the CSDE1 protein (arrow).| Product Name | CSDE1 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CSDE1; D1S155E; KIAA0885; NRU; UNR; Cold shock domain-containing protein E1; N-ras upstream gene protein; Protein UNR |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | D1S155E KIAA0885 NRU UNR |
|---|---|
| Alternative Names | CSDE1 D1S155E KIAA0885 NRU UNR Cold shock domain-containing protein E1 N-ras upstream gene protein Protein UNR |
| Molecular Weight(MW) | 88885 Da |
| Function | RNA-binding protein. Required for internal initiation of translation of human rhinovirus RNA. May be involved in translationally coupled mRNA turnover. Implicated with other RNA- binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding- region determinant of instability (mCRD) domain |
| Tissue Specificity | This CSDE1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 587-615 amino acids from the C-terminal region of human CSDE1. |
| Cellular Localization | Cytoplasm. |
| Entrez Gene | 7812 |
|---|---|
| Nucleotide Accession | NP_001123995.1 NP_001007554.1 |
Application
CSDE1 Antibody (C-term) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the CSDE1 antibody detected the CSDE1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
